Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in LYEL — Lyell Immunopharma, Inc.

CIK 70858 CHARLOTTE, NC
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$152,737
-$515,681 QoQ
Shares Held
10,871
-67.4% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 87 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. LYEL ranks #294 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in LYEL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $152,737 10,871
2026-03-31 $668,418 33,321
2025-12-31 $247,624 8,045
2025-09-30 $75,986 4,679
2025-06-30 $210,019 23,758
2025-03-31 $50,607 94,070
2024-12-31 $103,872 162,302
2024-09-30 $232,882 168,756
2024-06-30 $207,157 142,868
2024-03-31 $489,441 219,481
2023-12-31 $3,221,541 1,660,589
2023-09-30 $1,070,302 728,097
2023-06-30 $1,558,924 490,228
2023-03-31 $1,743,550 738,793
2022-12-31 $2,229,394 642,477
2022-09-30 $1,831,421 249,853
2022-06-30 $1,005,207 154,173
2022-03-31 $943,526 186,837
2021-12-31 $674,648 87,164
2021-09-30 $30,088 2,033
2021-06-30 $1,046,830 64,460